151029 20251017144629.0 doi 10.1007/s40618-021-01696-0 sideral 128457 ART-2022-128457 eng Corripio-Collado, R. Delphi consensus on the diagnosis and treatment of patients with short stature in Spain: GROW-SENS study; 34791604 2022 Access copy available to the general public Unrestricted Purpose: To identify consensus aspects related to the diagnosis, monitoring, and treatment of short stature in children to promote excellence in clinical practice. Methods: Delphi consensus organised in three rounds completed by 36 paediatric endocrinologists. The questionnaire consisted of 26 topics grouped into: (1) diagnosis; (2) monitoring of the small-for-gestational-age (SGA) patient; (3) growth hormone treatment; and (4) treatment adherence. For each topic, different questions or statements were proposed. Results: After three rounds, consensus was reached on 16 of the 26 topics. The main agreements were: (1) diagnosis tests considered as a priority in Primary Care were complete blood count, biochemistry, thyroid profile, and coeliac disease screening. The genetic test with the greatest diagnostic value was karyotyping. The main criterion for initiating a diagnostic study was prediction of adult stature 2 standard deviations below the target height; (2) the main criterion for initiating treatment in SGA patients was the previous growth pattern and mean parental stature; (3) the main criterion for response to treatment was a significant increase in growth velocity and the most important parameter to monitor adverse events was carbohydrate metabolism; (4) the main attitude towards non-responding patients is to check their treatment adherence with recording devices. The most important criterion for choosing the delivery device was its technical characteristics. Conclusions: This study shows the different degrees of consensus among paediatric endocrinologists in Spain concerning the diagnosis and treatment of short stature, which enables the identification of research areas to optimise the management of such patients. © 2021, The Author(s). info:eu-repo/semantics/openAccess by https://creativecommons.org/licenses/by/4.0/deed.es 5.4 2022 ENDOCRINOLOGY & METABOLISM 34 / 144 = 0.236 2022 Q1 T1 0.996 2022 Endocrinology, Diabetes and Metabolism 2022 Q2 Endocrinology 2022 Q2 8.1 2022 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Fernández-Ramos, C. González-Casado, I. Moreno-Macián, F. López-Siguero, J.P. Labarta-Aizpún, J. -I Universidad de Zaragoza (orcid)0000-0003-2832-2266 1011 670 Universidad de Zaragoza Dpto. Microb.Ped.Radio.Sal.Pú. Área Pediatría 45 (2022), 887-897 J. endocrinol. investig. Journal of endocrinological investigation 0391-4097 493153 http://zaguan.unizar.es/record/151029/files/texto_completo.pdf Versión publicada 2121459 http://zaguan.unizar.es/record/151029/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:151029 articulos driver 2025-10-17-14:25:18 ARTICLE